Journal List > Infect Chemother > v.40(1) > 1075394

Lee and Choi: Immunization Policy in Korea

Abstract

Immunization is the most effective and cost-beneficial means to prevent infectious diseases. So it has been regarded as one of the most important public health interventions in many countries and taken seriously in the aspect of national security related to smallpox and avian influenza. A variety of fields including production and distribution of vaccines, quality control of immunization, immunization registry, control of adverse events following immunization, and control of vaccine-preventable diseases should be considered for making and conducting the immunization policy. Korea has a long history of immunization since smallpox vaccination had been introduced in 1882, and many immunization strategies, including measles elimination program, have been carried out successfully. But there are still some problems to be solved for improving public health through immunization. KCDC (Korea Centers for Disease Control and Prevention) is making every effort to analyze and solve the problems, especially in the area of evidence-based policy-making, improving immunization coverage by supporting cost for vaccination, promoting public trust in immunization, laying the foundation for vaccine production, and eliminating vaccine-preventable diseases through immunization.

Figures and Tables

Fig. 1
Standard immunization schedule in Korea
ic-40-14-g001
Fig. 2
Structure of vaccine safety management in Korea.
Abbreviation:AEFI, adverse events after immunization.
ic-40-14-g002
Table 1
Korean History of Immunization*
ic-40-14-i001

Abbreviations:NIP, national immunization program; SIA, supplementary immunization activity

*Data source: Korea Centers for Disease Control and Prevention: Monthly Newsletter for National Immunization Program, 5(7):117-118, 2007

Table 2
Immunization Coverage in Korea (2006)*
ic-40-14-i002

Abbreviations:Hep B, hepatitis B JE, Japanese encephalitis

*Data source:Korea Centers for Disease Control and Prevention: Monthly Newsletter for National Immunization Program, 5(7):26, 2007

Private medical centers are assumed to report only 60% of actual immunization number based on previous research. So values from private medical centers were divided by 0.6 for correction

MMR coverage rate in this table is different from the result of the school-entry requirement for 2 doses of measles-containing vaccine (MCV2)

Table 3
Reported Number of Adverse Events Following Immunization in Korea*
ic-40-14-i003

Abbreviations:Hep B, hepatitis B; DTaP-O, DTaP with other vaccines; Var, varicella; JE, Japanese encephalitis JE-O, Japanese encephalitis vaccine with other vaccines HFRS, hemorrhagic fever with renal syndrome; Flu, influenza; Typ, typhoid fever

*Data source: Korea Centers for Disease Control and Prevention: Guideline for Management of Adverse Events Following Immunization, 2007

Catch-up campaign with MR vaccine was performed as a part of '5-Year Measles Elimination Program' in 2001

Report of adverse events after BCG vaccination was managed dualistically before 2005 and integrated from 2005

Table 4
Classification of Vaccines According to the Origin*
ic-40-14-i004

Abbreviations: IPV, inactivated polio vaccine; Hib, Haemophilus influenzaetype b, Hep A, hepatitis A Hep B, hepatitis B; JE, Japanese encephalitis; HPV, human papillomavirus; HFRS, hemorrhagic fever with renal syndrome

*Data source: Korea Centers for Disease Control and Prevention: Monthly Newsletter for National Immunization Program, 5(7):117-118, 2007

Table 5
Decreased Incidence of Vaccine Preventable Diseases in Korea*
ic-40-14-i005

*Data source: Korea Centers for Disease Control and Prevention: Monthly Newsletter for National Immunization Program, 5(7):111, 2007

A measles epidemic occurred between January 2000 and July 2001

Rubella was reported from 2000 by the revised raw

References

1. Division of Vaccine Preventable Disease Control and National Immunization Pregram, Korea Centers for Disease Control and Prevention. Monthly Newsletter for National Immunization Program. 2008. 5:117–118.
3. Korea Centers for Disease Control and Prevention. 2006. In : 2006 International Conference of Declaration in Measles Elimination in Korea Seoul;
4. Centers for Disease Control and Prevention. Elimination of measles-South Korea, 2001-2006. MMWR. 2007. 56:300–307.
5. World Health Organization. Elimination of measles in the Republic of Korea, 2001-2006. WER. 2007. 14:118–124.
10. Division of Vaccine Preventable Disease Control and National Immunization Program, Korea Centers for Disease Control and Prevention. Monthly Newsletter for National Immunization Program. 2007. 5:26.
16. National Institute of Infectious Disease. Measles, Japan, 2006-2007. IASR. 2007. 28:239–240.
21. Centers for Disease Control and Prevention. Global disease elimination and eradication as public health strategies. MMWR. 1999. 48:Suppl.
22. Alvarez Martha I., Begue Rodolfo E.. Eradication of infectious diseases: a goal for the next century. 1999. In : Infectious Diseases Society of America 37th annual meeting; Philadelphia.
23. Division of Vaccine Preventable Disease Control and National Immunization Program, Korea Centers for Disease Control and Prevention. Monthly Newsletter for National Immunization Program. 2007. 5:11.
24. Division of Vaccine Preventable Disease Control and National Immunization Program, Korea Centers for Disease Control and Prevention. Monthly Newsletter for the Prevention of HBV Vertical Transmission. 2007. 6:2.
25. Korea University, Korea Centers for Disease Control and Prevention. Influenza vaccination coverage rate and cost-effective analysis. 2006. 26–51.
TOOLS
Similar articles